Background: Prebiotics is a relatively neglected area in cancer research, despite evidence suggesting that it plays a key role in suppressing tumour growth and improving immune function.Recent Findings: Including prebiotics in the diet has been shown to strengthen the immune system and can better slow down or prevent the growth of tumours. It has also been strongly indicated in various scientific studies that prebiotics can contribute to the sustenance of a healthy microbiome, which in turn plays an important role in increasing the effectiveness and reducing the side effects of cancer treatments.Conclusion: In the present review article we highlight the mechanisms by which prebiotics like inulin, fructooligosaccharide (FOS), β‐glucan, pectin, and xylooligosaccharide (XOS) function. Furthermore, the beneficial effect of incorporating prebiotics during cancer therapy to improvise gut health and prevent/reverse the damage caused to patients due to chemotherapy has also been elaborated.
Electrospun nanofibers have been extensively investigated in recent years for the generation of various advanced sensing technique like high efficiency biosensors, chemosensors, colorimetric sensing strip, and nanofibrillar-based biosorbent for waste water management, remediation and environmental monitoring. The present review article highlights various different types of conventional sensors, their limitations and the further advancement towards development of highly sensitive sensor with faster response time using functionalized nanofibrous matrix. It also explains the various approaches for the generation of nanofibrous matrix through melt blowing, force spinning, template melt extrusion and electrospinning methods and their further modification with suitable probe for the detection and elimination of various water contaminants. This review discussed various nanofibrous matrices that have been modified for the sensing and remediation of heavy metals such as mercury (Hg), lead (Pb), copper (Cu), organic pollutants such as dye, petroleum, phenolic compounds, and microorganisms such as Escherichia coli (E. coli), BVDV (bovine viral diarrhoea virus), Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans). Finally, the various challenges and future perspectives associated with the usage of nanofibrous matrix-based sensors for detection and remediation of water pollutant are discussed.
The bottom-up approach of 3D bioprinting uses biopolymeric bioink along with the defined cells and allows to engineer 3D tissues/organs. The process is multistep, comprising upstream designing of matrix blueprints, bioinks, crosslinking strategies, and downstream maturation of construct using a bioreactor. The present review aims to provide a holistic picture of the various phases in 3D bioprinting, the methods used, and their clinical applications, such as in regenerative medicine, disease study, drug testing, and in situ bioprinting. Also, highlighted upgraded versions of 4D and 5D printing for better biomimetic properties and uses of 3D nanoprinting technology for effective tissue reconstruction. Graphical Abstract
Osteoarthritis is a common aging-related disorder that is confined mostly to the chondral layer of joints (e.g., the knee) but can spread to bony layers over time. In its early stages, osteoarthritis has minimal symptoms; however, these gradually worsen over time and include joint pain, stiffness, loss of mobility, and inflammation. The exposed subchondral bone of a Grade 4 osteoarthritic knee is highly prone to erosion if left untreated due to persistent rubbing between the bones, which can lead to painful bone spurs. However, treating osteoarthritis is especially challenging due to the poor mitotic potential and low metabolic activity of chondrocytes. Although currently available tissue-engineered products (e.g., BST-CarGel®, TruFit®, and Atelocollagen®) can achieve structural reconstruction and tissue regeneration, final clinical outcomes can still be improved. Major challenges faced during clinical studies of tissue-engineered constructs include chondrocyte hypertrophy and the development of mechanically inferior fibrous tissue, among others. These issues can be addressed by selecting suitable biomaterial combinations, mimicking the three-dimensional (3D) architecture of the tissue matrix, and better controlling inflammation. Furthermore, it is crucial to generate essential signaling molecules within the articular cartilage ecosystem. This approach must also account for the microarchitecture of the affected joint and support the chondrogenic differentiation of mesenchymal stem cells. The use of tissue-engineered constructs has the potential to overcome each of these challenges, since materials can be modified for drug/biomolecule delivery while simultaneously facilitating the regeneration of robust articular cartilage. Three-dimensional printing has been successfully used in tissue engineering to achieve bioprinting. By manipulating conventional 3D printing techniques and the types of bioink used, many different types of bioprinting have emerged. Overall, these bioprinting techniques can be used to address various challenges associated with osteoarthritis treatment.